CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Seeking Alpha Healthcare
Original article

Argenx upgraded at UBS; sees $20B peak sales in Vyvgart

VyvgartPositive
AI Analysis

Summary

UBS upgraded Argenx and provided a $20B peak sales forecast for Vyvgart. This represents analyst commentary on the company's commercial potential.

Financial Highlights

Revenue

$20B peak sales

Importance:4/10
Sentiment:
0.70
analyst upgradepeak sales forecastVyvgart
Related Companies

Read the original article

Published by Seeking Alpha Healthcare on August 26, 2026 1:59 PM

Read Original